Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
Battling With Booze? Here’s A Deeper Look At Ketamine for Alcohol Use Disorder
This article by Elisabetta Fato was originally published on Microdose and appears here with permission.
In the last decades, there has been a growing interest in psychedelics for the treatment of mood and behavioral disorders, among which are substance use disorders.
Science Feature: Next-Generation Psychedelics
This article was originally published on Microdose and appears here with permission.
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
Article by Jason Najum.
Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the industry to mature.
Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022
This article was originally published on Microdose and appears here with permission.
Psychedelic Front Runners MindMed , BioXcel Patent System To Identify Agitation
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission.
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
This article by Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission.
The psychedelic medicine industry continues to get attention and gain credibility in the investment world.